Somatotropin
- Generic Name
- Somatotropin
- Brand Names
- Genotropin, Humatrope, Norditropin, Norditropin Nordiflex, Nutropin, Nutropinaq, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive, NutropinAq
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 12629-01-5
- Unique Ingredient Identifier
- NQX9KB6PCL
- Background
Human growth hormone (HGH), also known as somatotropin, is a peptide hormone that is synthesized and secreted by the somatotropic cells of the anterior pituitary gland. Growth hormone plays an essential role in growth regulation during childhood as well as other basal metabolic functions, muscle and fat mass regulation, blood glucose level regulation, and li...
- Indication
Somatotropin is indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone, short stature associated with Turner syndrome, Prader-Willi syndrome (PWS), idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and shor...
- Associated Conditions
- Adult Onset Growth Hormone Deficiency, Cachexia, Childhood-onset Growth Hormone Deficiency, Growth Failure, HIV Wasting Syndrome, Short Bowel Syndrome (SBS), Short Stature
- Associated Therapies
- -
Growth Hormone Deficiency in Mild Traumatic Brain Injury
- Conditions
- Interventions
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 20
- Registration Number
- NCT05660356
Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2022-10-24
- Lead Sponsor
- Nanjing University
- Target Recruit Count
- 120
- Registration Number
- NCT05585177
- Locations
- 🇨🇳
Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study
- Conditions
- Interventions
- First Posted Date
- 2022-10-12
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 692
- Registration Number
- NCT05574894
- Locations
- 🇨🇳
Shanghai JIAI Genetics and IVF Institute, Shanghai, Shanghai, China
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
- Conditions
- Interventions
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 400
- Registration Number
- NCT05447208
- Locations
- 🇨🇳
Shanghai JIAI Genetics and IVF Institute, Shanghai, Shanghai, China
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Children's National Research Institute
- Target Recruit Count
- 1
- Registration Number
- NCT05382637
- Locations
- 🇺🇸
Children's National Hospital, Washington, District of Columbia, United States
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
- Conditions
- Interventions
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT05355272
- Locations
- 🇺🇸
VA Puget Sound Healthcare System, Seattle, Washington, United States
🇺🇸Michael E. DeBakey VA Medical Center, Houston, Texas, United States
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT05353192
- Locations
- 🇨🇳
Children's Hospital of Fudan University, Shanghai, Shanghai, China
Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Alexandria University
- Target Recruit Count
- 160
- Registration Number
- NCT05281341
- Locations
- 🇪🇬
faculty of medicine, Alexandria University, Alexandria, Egypt
Growth Hormone in Decompensated Liver Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2022-03-29
- Target Recruit Count
- 80
- Registration Number
- NCT05253287
- Locations
- 🇮🇳
Postgraduate Institute of Medical education and Research, Chandigarh, UT, India
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
- Conditions
- Interventions
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 45
- Registration Number
- NCT05187377
- Locations
- 🇺🇸
Seaver Autism Center for Research & Treatment, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.